American Academy of Audiology Position Statement on Early Identification of Cytomegalovirus in Newborns

Abstract

The American Academy of Audiology recommends early identification of congenital cytomegalovirus (cCMV) through screening to allow for appropriate early diagnosis, intervention, and monitoring for congenital, progressive, and delayed-onset hearing loss in infants with cCMV.

Early identification of cCMV is a valuable component in the diagnostic evaluation of infants with sensorineural hearing loss. The Academy recognizes the important role audiologists serve as clinical care providers and educators and advocates for early identification and audiological management of infants with cCMV.

Keywords

CMV - cCMV - congenital - cytomegalovirus - hearing loss - hearing screening - newborn - newborn screening

Approved by the Academy Board of Directors on March 7, 2023

Publikationsverlauf

Artikel online veröffentlicht:
27. März 2023

• References

• 1 Centers for Disease Control and Prevention. Babies born with congenital CMV. Accessed September 30, 2022 at: www.cdc.gov/cmv/congenital-infection.html
• 2 Akpan SU, Pillarisetty LS. Congenital cytomegalovirus infection. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2022. Accessed September 30, 2022 at: www.ncbi.nlm.nih.gov/books/NBK541003
• 3 Liming BJ, Carter J, Cheng A. et al. International Pediatric Otolaryngology Group (IPOG) consensus recommendations: hearing loss in the pediatric patient. Int J Pediatr Otorhinolaryngol 2016; 90: 251-258
• 4 National CMV. Foundation. What is CMV? Accessed September 30, 2022 at: https://www.nationalcmv.org
• 5 Doutre SM, Barrett TS, Greenlee J, White KR. Losing ground: awareness of congenital cytomegalovirus in the United States. J Early Hear Detect Interv 2016; 1 (02) 39-48
• 6 Diener ML, Shi K, Park AH. A cross-sectional study of caregiver perceptions of congenital cytomegalovirus infection: knowledge and attitudes about screening. J Pediatr 2020; 218: 151-156.e2
• 7 Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43 (09) 1143-1151
• 8 Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009; 46 (Suppl. 04) S6-S10
• 9 American Academy of Pediatrics. Cytomegalovirus infection. In: Red Book: 2021–2024 Report of the Committee on Infectious Diseases. Itasca: American Academy of Pediatrics; 2021
• 10 US Institute of Medicine Committee to Study Priorities for Vaccine Development. Vaccines for the 21st Century: A Tool for Decisionmaking. Stratton KR, Durch JS, Lawrence RS, eds. Washington, DC: National Academies Press; 2000
• 11 Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 2013; 57 (Suppl 4): S178-S181
• 12 Fowler KB. Congenital cytomegalovirus infection: audiologic outcome. Clin Infect Dis 2013; 57 (Suppl 4): S182-S184
• 13 Lanzieri TM, Chung W, Flores M. et al; Congenital Cytomegalovirus Longitudinal Study Group. Hearing loss in children with asymptomatic congenital cytomegalovirus infection. Pediatrics 2017; 139 (03) e20162610
• 14 Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics 2014; 134 (05) 972-982
• 15 Martin JRK, Huskins WC, Schimmenti LA, Cofer SA, Poling GL. Advancing clinical practice through integration of congenital cytomegalovirus (cCMV) testing with newborn hearing screening at Mayo Clinic. J Early Hear Detect Interv 2021; 6 (02) 28-38
• 16 Pesch MH, Schleiss MR. Emerging concepts in congenital cytomegalovirus. Pediatrics 2022; 150 (02) e2021055896
• 17 Rawlinson WD, Boppana SB, Fowler KB. et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 2017; 17 (06) e177-e188
• 18 Xu H, Zhang L, Xuan XY, Zhu M, Tang J, Zhao XK. Intrauterine cytomegalovirus infection: a possible risk for cerebral palsy and related to its clinical features, neuroimaging findings: a retrospective study. BMC Pediatr 2020; 20 (01) 555
• 19 Nassetta L, Kimberlin D, Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother 2009; 63 (05) 862-867
• 20 Cedeno-Mendoza R. Cytomegalovirus (CMV) treatment & management. Medscape 2021. Accessed September 30, 2022 at: https://emedicine.medscape.com/article/215702-treatment#showall
• 21 Hearing Health Foundation. Newborn hearing screening. Accessed September 30, 2022 at: https://hearinghealthfoundation.org/newborn-hearing-screening#:∼:text=Of%20babies%20who%20have%20their,before%203%20months%20of%20age
• 22 Gantt S, Dionne F, Kozak FK. et al. Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection. JAMA Pediatr 2016; 170 (12) 1173-1180
• 23 Hilditch C, Keir AK. Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection. Acta Paediatr 2018; 107 (05) 906
• 24 Boppana SB, Ross SA, Shimamura M. et al; National Institute on Deafness and Other Communication Disorders CHIMES Study. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011; 364 (22) 2111-2118
• 25 Diener ML, Zick CD, McVicar SB, Boettger J, Park AH. Outcomes from a hearing-targeted cytomegalovirus screening program. Pediatrics 2017; 139 (02) e20160789
• 26 Fowler KB, McCollister FP, Sabo DL. et al; CHIMES Study. A targeted approach for congenital cytomegalovirus screening within newborn hearing screening. Pediatrics 2017; 139 (02) e20162128
• 27 Suarez D, Ostrander B, Carey JP. Updated analysis of an expanded targeted early cytomegalovirus testing program. Otolaryngol Head Neck Surg 2022; 167 (1, Suppl) 134
• 28 Aaron KA, Kim GS, Cheng AG. Advances in inner ear therapeutics for hearing loss in children. Curr Otorhinolaryngol Rep 2020; 8 (03) 285-294
• 29 Joint Committee on Infant Hearing. Year 2019 position statement: principles and guidelines for early hearing detection and intervention programs—executive summary. Accessed September 30, 2022 at: http://www.jcih.org/JCIH_2019_Executive_Summary.pdf
• 30 Hoey AW, Pai I, Driver S, Connor S, Wraige E, Jiang D. Management and outcomes of cochlear implantation in patients with congenital cytomegalovirus (cCMV)-related deafness. Cochlear Implants Int 2017; 18 (04) 216-225
• 31 Torrecillas V, Allen CM, Greene T. et al. Should you follow the better-hearing ear for congenital cytomegalovirus infection and isolated sensorineural hearing loss?. Otolaryngol Head Neck Surg 2020; 162 (01) 114-120
• 32 Dhondt C, Maes L, Rombaut L. et al. Vestibular function in children with a congenital cytomegalovirus infection: 3 years of follow-up. Ear Hear 2021; 42 (01) 76-86